Home › Funds › PSP Research LLC › CTMX

PSP Research LLC position in CTMX

CYTOMX THERAPEUTICS INC. · Health Care

PSP Research LLC reported holding 39,400 shares of CTMX (CYTOMX THERAPEUTICS INC.) in its Q3 2026 13F filing — a position valued at US$107K, representing 0.07% of its reported portfolio and ranking #42 among its reported holdings. PSP Research LLC has disclosed CTMX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)39.40K sh
Reported value held$107.17K
Portfolio Weight0.07%
First reportedQ2 2026
Last changeHold
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How PSP Research LLC's CTMX position evolved

PSP Research LLC first disclosed a stake in CTMX in Q2 2026 at 39,400 shares (US$148K). Across 2 filings, PSP Research LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 39,400 shares valued at US$107K.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 39.40K $147.75K New
Q3 2026 39.40K $107.17K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CTMX and 13F data

CTMX (CYTOMX THERAPEUTICS INC.) is a Health Care company. 46 other funds we track also report a position in CTMX — the largest reported positions include Kynam Capital Management, LP (US$81.4M), PERCEPTIVE ADVISORS LLC (US$39.1M), Venrock Adviser, LLC (US$18.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CTMX

All CTMX fund holders →

FAQ

How long has PSP Research LLC held CTMX?

PSP Research LLC has disclosed CTMX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is PSP Research LLC's current position in CTMX?

As of Q3 2026, PSP Research LLC holds 39.40K shares of CTMX (CYTOMX THERAPEUTICS INC.), valued at $107.17K, representing 0.07% of its reported portfolio and ranking #42.

Has PSP Research LLC been buying or selling CTMX?

In the latest 13F filing (Q3 2026), PSP Research LLC held unchanged its position in CTMX.

Which other funds hold CTMX?

Other major institutional holders of CTMX include Kynam Capital Management, LP, PERCEPTIVE ADVISORS LLC, Venrock Adviser, LLC, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.